Transurethral resection vs microwave thermotherapy of the prostate: a cost‐consequences analysis

To compare the costs and outcome of high‐energy transurethral microwave thermotherapy of the prostate (HE‐TUMT) with transurethral resection of the prostate (TURP), as the former is considered to be the best minimally invasive method for managing lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).

[1]  W. Mebust,et al.  Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. , 2002, The Journal of urology.

[2]  L. Kiemeney,et al.  Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. , 2001, The Journal of urology.

[3]  M. Manyak,et al.  Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II--results. , 2000, Urology.

[4]  L. Kiemeney,et al.  High energy transurethral microwave thermotherapy for the treatment of patients in urinary retention. , 2000, The Journal of urology.

[5]  J. Donovan,et al.  A guide to undertaking economic evaluations within randomized controlled trials of treatments for lower urinary tract symptoms , 2000, BJU international.

[6]  D. Cranston,et al.  A double‐blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3‐year follow‐up , 2000, BJU international.

[7]  J. Roberts,et al.  Immediate and postoperative complications of transurethral prostatectomy in the 1990s. , 1999, The Journal of urology.

[8]  A. Bitton,et al.  Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: results in 134 patients after 1 year. , 1999, The Journal of urology.

[9]  C. Sternberg,et al.  Comparison of the BTA statTM Test with Voided Urine Cytology and Bladder Wash Cytology in the Diagnosis and Monitoring of Bladder Cancer , 1999, European Urology.

[10]  N. Gordon.  Catheter-free same day surgery transurethral resection of the prostate. , 1998, The Journal of urology.

[11]  H. Stoevelaar,et al.  The economic impact of introducing transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia: a scenario analysis , 1998, World Journal of Urology.

[12]  R. Bruskewitz,et al.  Economics of transurethral thermotherapy of the prostate , 1998, World Journal of Urology.

[13]  P. Fayers,et al.  Generalisation from phase III clinical trials: survival, quality of life, and health economics , 1997, The Lancet.

[14]  N. Gordon,et al.  Transurethral resection of the prostate: still the gold standard. , 1997, The Australian and New Zealand journal of surgery.

[15]  J. J. de la Rosette,et al.  Current status of thermotherapy of the prostate. , 1997, The Journal of urology.

[16]  C. Frimodt-Møller,et al.  Does old age contraindicate TURP. , 1997, European urology.

[17]  M C Weinstein,et al.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[18]  T. Chirikos,et al.  Cost consequences of surveillance, medical management or surgery for benign prostatic hyperplasia. , 1996, The Journal of urology.

[19]  A. Hillman,et al.  Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia. , 1995, Urology.

[20]  P. Boyle,et al.  Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia. , 1995, Urology.

[21]  M. Barry,et al.  Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes. Prostate Patient Outcomes Research Team (PORT). , 1994, Urology.

[22]  M. B. Brown,et al.  Epidemiology of bladder emptying symptoms in elderly men. , 1992, The Journal of urology.

[23]  H. Lepor,et al.  The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism. , 1990, The Journal of urology.

[24]  K McPherson,et al.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. , 1989, The New England journal of medicine.

[25]  A T Cockett,et al.  Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. , 1989, The Journal of urology.